ADVERTISEMENT

Pharmaceutical company says encouraged by cancer drug atezolizumab study

It showed that 84 percent of people who responded to atezolizumab continued to respond regardless of their PD-L1 status when the results were assessed with longer median follow-up of 11.7 months.

Roche says encouraged by cancer drug atezolizumab study

Roche, the world's biggest maker of cancer drugs, said a mid-stage trial of atezolizumab in people with locally advanced or metastatic urothelial carcinoma (mUC), showed median overall survival of 11.4 months in people with higher levels of PD-L1 expression and 7.9 months in the overall study population.

The therapy was well tolerated and adverse events were consistent with those observed in previous updates, it said.

"It is encouraging to see that the majority of people with advanced bladder cancer who responded to atezolizumab maintained their response with longer follow up," said Sandra Horning, Roche's chief medical officer and head of global product development.

Roche plans to submit the data soon to health authorities and the U.S. Food and Drug Administration under breakthrough therapy designation designed to speed the development and review of medicines that may demonstrate substantial improvement over existing therapies for serious diseases.

Enhance Your Pulse News Experience!

Get rewards worth up to $20 when selected to participate in our exclusive focus group. Your input will help us to make informed decisions that align with your needs and preferences.

I've got feedback!

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.
ADVERTISEMENT

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.ng

Recommended articles

Immigration places wanted Yahaya Bello on watchlist, unveils his passport details

Immigration places wanted Yahaya Bello on watchlist, unveils his passport details

Oyo govt justifies demolition of Yoruba Nation agitators’ building

Oyo govt justifies demolition of Yoruba Nation agitators’ building

NAFDAC raids popular supermarket in Abuja for selling counterfeit products

NAFDAC raids popular supermarket in Abuja for selling counterfeit products

Iranian morality police crack down on women who don't wear headscarves

Iranian morality police crack down on women who don't wear headscarves

FG sets up committee to compensate landowners affected by Lagos-Calabar road project

FG sets up committee to compensate landowners affected by Lagos-Calabar road project

Kano Gov remains a bona fide member of our party - NNPP debunks suspension

Kano Gov remains a bona fide member of our party - NNPP debunks suspension

We need ₦3.2trn to pay electricity subsidy in 2024 - FG

We need ₦3.2trn to pay electricity subsidy in 2024 - FG

Tinubu's proactive approach to security threats yielding results, Ribadu claims

Tinubu's proactive approach to security threats yielding results, Ribadu claims

You will not walk alone - Gov Oyebanji assures late APC chairman’s family

You will not walk alone - Gov Oyebanji assures late APC chairman’s family

Pulse Sports

Lionel Messi's son breaks the internet after scoring five goals for Inter Miami

Lionel Messi's son breaks the internet after scoring five goals for Inter Miami

Naija Stars Abroad: Onyedika, Boniface, and Osimhen shine across Europe

Naija Stars Abroad: Onyedika, Boniface, and Osimhen shine across Europe

Victor Osimhen and Tobi Amusan make list of Forbes’ 30 under 30 Class of 2024

Victor Osimhen and Tobi Amusan make list of Forbes’ 30 under 30 Class of 2024

ADVERTISEMENT
ADVERTISEMENT